(Q39764556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

review article

1 reference

title

Oral contraceptives and neoplasia: 1987 update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

G R Huggins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

P K Zucker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

language of work or name

English

0 references

publication date

1 May 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

733-761

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

Mortality Associated with the Control of Fertility

28 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Possible association between benign hepatomas and oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Evaluation of rare adverse effects of systemic contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Some problems arising in prospective and retrospective studies of the etiology of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Matching in retrospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Retrospective studies. A review for the clinician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Sample size requirements in cohort and case-control studies of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Epidemiological Problems Associated With Studies of the Safety of Oral Contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Menopausal estrogen use and risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Breast cancer and estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Exogenous estrogen and breast cancer after bilateral oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Genetic factors in the etiology of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Natural history of breast cancer:Progression from hyperplasia to neoplasia as predicted by angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Chronic mastopathy and breast cancer. A follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptives and breast neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral Contraceptives and Reduced Risk of Benign Breast Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral Contraceptives as Related to Cancer and Benign Lesions of the Breast 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Epidemiology of Benign Breast Lesions: Lack of Association with Oral Contraceptive Use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Risk factors for benign breast disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The pill, estrogens, and the breast.Epidemiologic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptives and breast disease. An epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral Contraceptives and Breast Neoplasia: A Retrospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Breast cancer and oral contraceptives: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Breast cancer and oral contraceptive use: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Characteristics that predict risk of breast cancer before and after the menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Breast cancer in relation to patterns of oral contraceptive use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptive use and early abortion as risk factors for breast cancer in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptives and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral-contraceptive use and the risk of breast cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Estimability and estimation in case-referent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Epidemiology of cancer of the cervix. II. Marital and coital factors in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Age at first coitus and choice of contraceptive method: Preliminary report on a study of factors related to cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The impact of hormonal contraceptive therapy on a community and effects on cytopathology of the cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Steroid contraceptive use and cervical dysplasia: increased risk of progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptives and cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The incidence of cervical cancer and duration of oral contraceptive use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Long-term use of oral contraceptives and risk of invasive cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Invasive cervical cancer and combined oral contraceptives. WHO collaborative study of neoplasia and steroid contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Ovarian cysts and hormonal contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The noncontraceptive health benefits from oral contraceptive use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

"Incessant ovulation" and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The woman at risk for developing ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Ovarian cancer.Incidence and case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

An epidemiologic study of epithelial carcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Incidence of ovarian cancer in relation to the use of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptives and risk of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Secretory rates of human chorionic gonadotropin by normal trophoblast.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Multifactorial regulation of prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Current Concepts of Prolactin Physiology in Normal and Abnormal Conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Neuroendocrine Dysfunction in Galactorrhea-Amenorrhea After Oral Contraceptive Use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Pathogenesis of prolactin-secreting pituitary adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The significance of glactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Mechanisms of Action of Steroid Hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The in vivo regulation of the progesterone "receptor" in guinea pig uterus: dependence on estrogen and progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Control of Uterine Estrogen Receptor Levels by Progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Progesterone Binding by Normal and Abnormal Human Endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Progestin therapy in endometrial hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Hormones in the etiology and prevention of breast and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Estrogens and Endometrial Cancer in a Retirement Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Association of Exogenous Estrogen and Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Exogenous estrogen and endometrial carcinoma: Case-control and incidence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Endometrial cancer and estrogen use. Report of a large case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

The development of adenocarcinoma of the endometrium in young women receiving long-term sequential oral contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Incidence of endometrial cancer in relation to the use of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Decreased Risk of Endometrial Cancer among Oral-Contraceptive Users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Ultrastructural findings in a well-differentiated hepatoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Liver Tumors and Contraceptive Steroids: Experience With the First One Hundred Registry Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Contraceptive steroids and liver lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Oral contraceptives and benign liver tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Regression of liver cell adenomas associated with oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Hepatic adenoma. Observations after estrogen withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Role of oral contraceptive agents in the pathogenesis of liver tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Letter: Liver-cell neoplasms and oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Hepatomas in young women on oral contraceptives: Report of two cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Hepatocellular carcinoma and oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Cancer of the liver and the use of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

7 January 2021

Oral contraceptives and prolactinomas: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

7 January 2021

Histology of the endometrium in long-term use of a sequential oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

7 January 2021

Liver neoplasms and the oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

7 January 2021

Androgen-induced hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959160-2

7 January 2021

10.1016/S0015-0282(16)59160-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3552751%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference